These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 25714535)
21. Bilateral simultaneous intravitreal injections in the office setting. Bakri SJ; Risco M; Edwards AO; Pulido JS Am J Ophthalmol; 2009 Jul; 148(1):66-9.e1. PubMed ID: 19403114 [TBL] [Abstract][Full Text] [Related]
22. [Extemporaneous withdrawal with a mini-spike filter: A low infection risk technique for drawing up bevacizumab for intravitreal injection]. Le Rouic JF; Breger D; Peronnet P; Hermouet-Leclair E; Alphandari A; Pousset-Decré C; Badat I; Becquet F J Fr Ophtalmol; 2016 May; 39(5):415-20. PubMed ID: 27155911 [TBL] [Abstract][Full Text] [Related]
23. Survey among retina specialists in Brazil about inflammatory reactions after intravitreal antiangiogenic therapy. Melo GB; Ferreira M; Maia M Arq Bras Oftalmol; 2020 Jun; 83(3):175-179. PubMed ID: 32049159 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of intravitreal injection of aflibercept in neovascular age-related macular degeneration with or without choroidal vascular hyperpermeability. Hata M; Oishi A; Tsujikawa A; Yamashiro K; Miyake M; Ooto S; Tamura H; Nakanishi H; Takahashi A; Yoshikawa M; Yoshimura N Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7874-80. PubMed ID: 25395483 [TBL] [Abstract][Full Text] [Related]
25. Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2,000 injections. Ladas ID; Karagiannis DA; Rouvas AA; Kotsolis AI; Liotsou A; Vergados I Retina; 2009 Mar; 29(3):313-8. PubMed ID: 19287287 [TBL] [Abstract][Full Text] [Related]
26. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743 [TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of pazopanib eye drops versus ranibizumab intravitreal injections in subjects with neovascular age-related macular degeneration. Csaky KG; Dugel PU; Pierce AJ; Fries MA; Kelly DS; Danis RP; Wurzelmann JI; Xu CF; Hossain M; Trivedi T Ophthalmology; 2015 Mar; 122(3):579-88. PubMed ID: 25432081 [TBL] [Abstract][Full Text] [Related]
28. Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals. Antoszyk AN; Baker C; Calzada J; Cummings H; So J; Quezada-Ruiz C; Haskova Z PDA J Pharm Sci Technol; 2018; 72(4):411-419. PubMed ID: 29853609 [TBL] [Abstract][Full Text] [Related]
34. Comparison of 3 different anesthetic approaches for intravitreal injections: a prospective randomized trial. Andrade GC; Carvalho AC Arq Bras Oftalmol; 2015; 78(1):27-31. PubMed ID: 25714534 [TBL] [Abstract][Full Text] [Related]
35. Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration. Landa G; Amde W; Doshi V; Ali A; McGevna L; Gentile RC; Muldoon TO; Walsh JB; Rosen RB Ophthalmologica; 2009; 223(6):370-5. PubMed ID: 19590252 [TBL] [Abstract][Full Text] [Related]
36. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations]. Małgorzata F Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123 [TBL] [Abstract][Full Text] [Related]
37. Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Stewart JM; Srivastava SK; Fung AE; Mahmoud TH; Telander DG; Hariprasad SM; Ober MD; Mruthyunjaya P Ocul Immunol Inflamm; 2011 Feb; 19(1):32-8. PubMed ID: 21034310 [TBL] [Abstract][Full Text] [Related]